Source link : https://www.newshealth.biz/health-news/will-game-changer-antipsychotic-live-up-to-the-hype/
The US Food and Drug Administration (FDA) is due to issue a decision by September 26 on the approval of KarXT, a potential first-in-class antipsychotic. If approved, it would be the first drug with a novel mechanism to treat schizophrenia in decades. Developed by Karuna Therapeutics, now part of Bristol Myers Squibb, KarXT has been […]
Author : News Health
Publish date : 2024-09-20 13:53:20
Copyright for syndicated content belongs to the linked Source.
in Health